BBC News coverage of Callavid®
Grateful to BBC News for spotlighting our work on progesterone-Callavid®, our novel drug delivery technology aimed at helping treat threatened miscarriage. “The current delivery method can leak and cost the [British economy and] NHS up to £236m per year, health economists say. University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is leading the trial and …
Lia Mae Pellegrini joins as Product Development Engineering Intern
We are excited to welcome Lia Mae Pellegrini as a Product Development Engineering Intern! Lia Mae holds a First Class Honours Master’s in Product Design Engineering from Queen’s University Belfast, where in her final year of university she reached the finals of both the Co-Founders programme run by the Northern Ireland tech hub Catalyst and …
UHCW NHS Trust News
Trust leads clinical trial of pioneering product to tackle threatened miscarriage 8 April 2025 Experts from University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are to lead a clinical trial of a novel device aimed at addressing threatened miscarriage. More than 150,000 women a year in the UK could be helped by Callavid® which is designed …
CLCC at Microbes in Women’s Health Congress – Amsterdam
Our colleague Elham Shirani will be at the second Microbes in Women’s Health Congress in Amsterdam on 9-10 April. 🇳🇱 We’re excited to meet with existing and new partners for 2 days of talks, panels and networking. Our user convenient Callavid® drug delivery platform will help provide effective colonisation and epithelial adherence of live biotherapeutics …
NIHR news: New trial to test device treating threatened miscarriage
[From NIHR: National Institute for Health and Care Research] We have awarded £1 million in funding to a first of its kind technology that’s being trialled to address threatened miscarriage. Currently, over 150,000 women in the UK experience threatened miscarriage a year. If approved, the device would become the world’s first drug-device combination to treat …
Raising funding for Tommy’s Charity 🏃♀️
🎉 Congratulations to our colleague Sabrina Franco for completing the London Landmarks Half Marathon in support of Tommy’s – the pregnancy and baby charity! We’re proud to support Sabrina’s great work and efforts in raising awareness and funds for such an important cause. 💙
CLCC awarded £1m NIHR funding to address threatened miscarriage
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …
Miscarriage Prevention: What Science Can Do And Why It’s Not Your Fault
Miscarriage. You can find lots of definitions, from the rather cold “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,” to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …
Int’l Women’s Day
A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …
Lara Joins Springboard Women’s Health Accelerator 2025 Cohort
Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort! Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working …